language |
eng
|
Author |
Liu Guangyan
1College of Basic Medical Sciences, Shenyang Medical College, Shenyang 110034, China. 2Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China. 3Department of Molecular Genetics, Kanazawa University, Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
Ma Xiancai
Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
Wang Zhe
Department of Molecular Genetics, Kanazawa University, Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan. / Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China. / The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Dalian University, Dalian 116001, China.
Wakae, Kousho
Department of Molecular Genetics, Kanazawa University, Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
Yuan Yaochang
Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
He Zhangping
Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
Zhang Hui
Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China.
Matsuda, Mami
Department of Virology II, National Institute of Infectious Disease, Tokyo 164-8640, Japan.
Sugiyama, Ryuichi
Department of Virology II, National Institute of Infectious Disease, Tokyo 164-8640, Japan.
Yuan Zhiyu
College of Basic Medical Sciences, Shenyang Medical College, Shenyang 110034, China.
Muramatsu, Masamichi
Department of Molecular Genetics, Kanazawa University, Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa 920-8640, Japan muramatu@med.kanazawa-u.ac.jp muramatsu@nih.go.jp.
Li Linghua
Department of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510060, China llheliza@126.com.
|
Subject | interferon; hepatitis B virus (HBV; Hep B); microRNA (miRNA); p53; cytidine deaminase; RNA editing; ADAR1; cyclin G1; HBV; miR-122; p53
|
Journal Title |
JOURNAL OF BIOLOGICAL CHEMISTRY
|
Volume | 294
|
Issue | 38
|
Start Page | 14043
|
End Page | 14054
|
ISSN | 0021-9258
|
ISSN(Online) | 1083-351X
|
Published Date | 2019-09-20
|
DOI | |
PubMed ID | |
Publisher | AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
|
NII Type |
Journal Article
|
OAI-PMH Set |
Faculty of Medicine
|
Remark | This work was supported by National Natural Science Foundation of China Grant 81702856, Natural Science Foundation of Guangdong Province China Grant 2017A030310231, Liaoning Provincial Natural Science Foundation of China Grant 20180530041, and National Natural Science Foundation of China Grant 81501753, and the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED) Grant 18fk0310103j0302. The authors declare that they have no conflicts of interest with the contents of this article.
|